2014-2-Razavi

JRHS 2014; 14(2): 163-166

Copyright© Journal of Research in Health Sciences

Prevalence of Anabolic Steroid Use and Associated Factors among Bodybuilders in Hamadan, Western Province of Iran

Zahra Razavi (MD)a, Babak  Moeini (PhD)b, Yones Shafiei (MD)c and Hassan Bazmamoun (MD)c*

a Department of Pediatrics, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran

b Social Determinants of Health Research Center & Department of Public Health, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran

c Department of Pediatrics, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran

* Correspondence: Hassan Bazmamoun (MD), E-mail: hbazmamoun@yahoo.com

Received: 19 November 2013, Revised: 28 December 2013, Accepted: 29 January 2013, Available online: 15 February 2014

Abstract

Background: Androgenic-anabolic steroids (AAS) are abused by a growing number of bodybuilders. This descriptive cross-sectional study was conducted to determine prevalence and patterns of AAS use by bodybuilders in Hamadan, western Iran.

Methods: In this cross-sectional study, participants were recruited from five gym clubs in two area of Hamadan (a total of 10 clubs). Twenty-five bodybuilders from each club were administered. Questions investigating demographic information, sport history, education level, general knowledge about AAS, and their side effects were asked. Statistical analysis was performed using SPSS 16.

Results: The frequency of AAS use was 28.8% (72/250). Fifty-four percent of users were 25 years or younger. AAS abuse showed a significant association with duration of exercise. The drugs were suggested mostly from peers (43.1%) and coaches (36.1%). The most commonly consumed anabolic steroid was testosterone (66.7%). The most commonly reported AAS side effect was acne (18.1%). There was not significant association between general knowledge about side effects of ASS and their use.

Conclusions: The results of current survey indicate that frequency of ASS use is high in adolescents and young adult bodybuilders. Well educated bodybuilders have a higher prevalence of abuse. Awareness about the side effects of drugs is not deterrent factor for their abuse. Iranian Ministry of Sport and the Youth, and the National Council for Youth, should be urged to conduct more effective prevention strategies.

Keywords: Anabolic agents, Steroids, Athletes, Adverse effects

Introduction

Anabolic-androgenic steroids (AAS) are synthetically produced variants of testosterone and have specific therapeutic indications1. AAS adverse effects range from hirsutism, acne, clitoral enlargement and deepened voice in women to hypertension, heart hypertrophy, myocardial infarction, decreased high-density lipoprotein, fluid retention, liver failure, kidney damage, personality disturbance, mood fluctuation, prostatic hypertrophy and certain cancers1.

Since the 1950s, competitive athletes began to use AAS for enhance their performance in competitions and body image purposes. AAS abuse has increased and its use is no longer limited to competitive athletes; high school students, adolescents, females and non-competitive athletes also use them2,3. In the USA, approximately one million Americans were estimated to have abused AAS in the 1980s, men having a higher prevalence of use than women 4-6. According to Rachoń survey in Poland, the prevalence of anabolic-androgenic steroids use was 6.2% among males and 2.9% among females 7.

While various surveys have described the frequency, risk factors and patterns of AAS use among athletes and general population in other countries, there is a scarcity of studies with regard to AAS abuse in our region. Therefore, in an effort to obtain more insight on the profile of AAS use, this study aimed firstly, to estimate the frequency of AAS use, and secondly, to study some characteristics of AAS user bodybuilders in Hamadan, western Iran.

Methods

This cross-sectional study was conducted among male bodybuilding gym attendants in 2011 in Hamadan City; the west of Iran. The study was approved by the local Ethics Committee of Hamadan University of Medical Sciences. All subjects gave their written informed consent before participating.

By using the following sample size estimating formula and according to previous study results in past years8 and assuming: P=0.20, d=0.05 and 95% significant level, the sample size was calculated 245 subjects and with assuming 10% attrition, it was 270 persons finally 9.  

Hamadan with more than 700,000 inhabitants has 2 distinct major areas. Five clubs randomly selected from each area and in the next step by simple random sampling method, 27 persons were selected from each club registering list. All attendant athletes were extensively informed about the objectives and approach of the study, and their right to refuse to participate. This included a total sample of 270 of which 250 athletes participated voluntarily in this study (response rate of 92.6%).

The participants were asked to complete a self-administered, voluntary, and anonymous questionnaire. The questions asked about age, marital status, education level, sport duration, weekly duration of the exercise, habit of administration, form and methods of abuse, and general knowledge about ASS. In the questionnaires, we had asked questions to determine participants knowledge about the effects and side effects of AAS divided into two groups of “low” and “good” knowledge.

The major inclusion criteria were age between 15-45 years of old, and strength training experience for a minimum period of three months and, at least three sessions per week. Those who declined the participation in the study, receiving any additional medications, or developed acute or chronic illnesses that impair survey were excluded from the study.

The Students t-test was used to compare means of groups. Statistical comparisons of other variants between the groups were performed by chi-square analytic test. The level of P-value less than 0.01 was considered statistically significant.

Results

The mean age of participants was 25.52 (ranging between 15 and 45 years of old).Twenty three point six percent (17) of AAS user were in age group of 15-20 years, 30.6% (22) in 20-25 years, 26.4% (19) in 25-30 years, 13.9% (10) in 30-40 years and 5.6% (4) were more than 40 years. The majority of participants (71.2%) were single and 23.6% of them were married.

In total, 72 athletes (28.8%) were self-reported AAS users. The most frequently used AAS was testosterone (66.7%) followed by nandrolone (15.3%), oxymetholone (5.6%), and other types of AAS (12.4%). Intramuscular injection was the most frequently used method in abuser group (63.8%) whereas oral (pill) and combination methods were -each one- used by 18.1% of participants in this group. More than half of abuser group (56.9%) had not reported any type of AASs side effects, whereas acne had been reported in 18.1% of them, changes in libido in 9.7%, some degrees of aggression in 6.9%, hair loss in 4.1%, breast enlargement in 1.4%, and other side effects in 2.8%.

The AAS users differed markedly from the nonusers on some variables (Table 1).We found a significant statistical relationship between the duration of exercise and frequency of AAS abuse (P<0.001). Using χ2 test, no significant statistical relationship was found between use of AAS and the level of athletes knowledge  about AAS and their side  effect (P=0.150).

According to duration of AAs abuse, 25 (34.7%) had used for less than six months, 12(16.7%) for 6-12 months, 8 (11.1%) for 13-24 months and 27 (37.5%) for 25 months -12 years.

The drugs were recommended by peers (43.1%), coaches (36.1%), magazine (9.7%) and internet (6.9%). According the educational level, there was no statistical significant relationship between the educational level and the frequency of AAS abuse (χ2 test, P=0.052).

Table 1: Comparisons of the variables between Androgenic-anabolic steroids users and nonusers

Discussion

This research investigated the frequency and characteristics of androgenic anabolic steroids abusers among bodybuilders in Hamadan, Iran. The findings of this study clearly reveal that number of AAS users among bodybuilders is alarming (28.8%). It was also found that AAS use is particularly common in age range of 15-25 years. The observed frequency indicate the need for effective measures to prevent steroid abuse among youth. In literature focusing on the frequency of AAS or other controlled substances abuse among bodybuilders in Middle East, similar data has been described. For example, the prevalence of AAS abuse has been reported as 26% among Jordanian bodybuilder athletes in 20089. Similarly, the data from Angoorani et al. survey in Tehran, capital city of Iran, indicated that 13.3% of body builders were amphetamine user10. According to one study by Khooshabi et al. among high schools students in Tehran, 10.1% of males and 6.4% of females reported lifetime use of controlled substances use 11.

Several other studies have shown similar results in western countries. Abuse of AAS among college athletes in the USA is reported 17-20% 12. The prevalence rate of approximately 38%58% among bodybuilders and weight lifters have been found in Delbeke et al. study´s in Flanders13. Johnson et al. demonstrated that among the amateur bodybuilders, 80% of men and 40% of women had used illicit drug14.

The findings of current study showed that 54% of users were 25 years or younger. This is important and represents that adolescents and young adults are main risk groups for AAS abuse. Effective AAS prevention therefore needs to focus on this age group. The association between AAS use and younger age is consistent with previous data published by others 3, 7, 15. Rachoń et al. also reported that the abuse of AAS is a serious health problem among adolescents and young adults in Poland7.

The most commonly abused drugs in current study were testosterone, nandrolone, and oxymetholone. In our country, AAS are prescription drugs; still abusers can easily acquire them. It is reasonable to assume that abusers can obtain drugs through the pharmacist, without prescription. Abusers may also receive them on the black market, supermarkets or by vendors. Efforts and intervention should be also expanded for prevention of the easy access to these drugs.

This study showed a wide duration range of AAS use among 72 AAS abusers (six months -12 years), but it is a very grave situation that the majority of abusers (37.5%) were using them more than two years. This study showed, not surprisingly, that most of the abusers had been offered to use AAS by their friends and coaches. This revealed that abusers are highly influenced by groups and trainers, important factor that should be taken into consideration for preventive strategies. Importantly, there was significant association between duration of practice and AAS use. In other words, attitudes towards anabolic administration increased with the more year of physical training. It seems that abuse of androgenic anabolic steroids can be decreased by preventive work concentrated on whom with more sport history.

The present findings demonstrated that AAS users did not differ significantly from nonuser group on educational attainment variable. Interestingly, well-educated bodybuilders have a higher prevalence of abuse. This means that having higher education necessarily is not a protective factor for anabolic steroid use. In line of this finding, a recent study in Iranian body builders, demonstrated higher educational degree was associated with a higher likelihood of amphetamine use10. In contrast, results obtained by some authors pointed out that abuse of AAS was associated with lower education 15, 16.

As in some previous studies7, this survey reveals more than one half of the abuser participants were using AAS in the form of intramuscular injection. Baker et al. indicated that nearly 100% of AAS users were self-administer intramuscular injection 19. Parkinson et al. and Baker  et al. pointed out that, 10 and 13% users respectively, reporting hazardous injection techniques 16, 19. In addition, in current work more than half of AAS users (56.9%) reported subjective AAS side effect. Acne, sexual disorder, some degrees of aggression and hair loss were the most commonly reported subjective AAS side effect.This is less than expected and may be due to low doses administered in abusers, since we did not investigate doses used by steroid users. In study by Parkinson et al., 99.2% (496/500) of AAS users reported subjective side effects 16.

It should also be mentioned that the majority of abusers had high knowledge about drug's side effects. Therefore use of androgenic anabolic steroids seems to be related to various factors other than educational attainment and awareness about the adverse effects of AAS. Our findings concur with one previous study by Goldberg et al. that indicated appropriate educational programs increased abuse of androgenic anabolic steroids among adolescents 20.

Several limitations of current study should be considered. First; we might have underestimated frequency of AAS abuse and their side effects, because all data were self-reported, and some of the study participants who used AAS might have not disclosed their use or side effects. Second; the main reason for taking and sources of obtaining AAS among abuser group has not been investigated. Third; the relationship between the use of AAS and other performance-enhancing agents, supplements, alcohol and  other illicit drug use have not shown in this study. Further studies are needed in order to consider bias of current work.

Conclusions

Findings of this study indicate that frequency of ASS use is high in adolescent and young adult bodybuilders. Awareness about the side effects of AAS and university qualifications is not deterrent factor for their abuse. Why this is so needs to be investigated by further surveys. Further studies are also needed in order to investigate underlying and psychological reasons for AAS use. Abusers are highly influenced by groups and coaches, effective AAS prevention therefore need to focus on this important factor as well. Finding of current study highlights that Iranian Ministry of Sport and the Youth and the National Council for Youth need to implement the effective measures to prevent steroid abuse among Iranian youth. Efforts should be also expanded for prevention of the easy access to these drugs.

Acknowledgements

We would like to express our sincere thanks and deep gratitude to participants for allowing us to complete this study.

Conflicts of interest

The authors have nothing to be declared.

Funding

No sources of support provided

References

  1. Van Amsterdam J, Opperhuizen A, Hartgens F. Adverse health effects of anabolic-androgenic steroids. Regul Toxicol Pharmacol. 2010;57(1):117-123.
  2. Bhasin S, Storer TW, Berman N, Callegari C, Clevenger B, Phillips J, et al. The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. N Engl J Med. 1996; 335:1-7.
  3. Dunn M, White V. The epidemiology of anabolic-androgenic steroid use among Australian secondary school students. J Sci Med Sport. 2011;14(1):10-14.
  4. Yesalis CE. Use of steroids for self-enhancement: an epidemiologic/societal perspective. AIDS Read. 2001;11(3):157-160.
  5. Kashkin KB, Kleber HD. Hooked on hormones? An anabolicsteroid addiction hypothesis. JAMA. 1989;262:3166-3170.
  6. Tokish JM, Kocher MS, Hawkins RJ. Ergogenic aids: a review of basic science, performance, side effects, and status in sports. Am J Sports Med. 2004;32:1543-1553.
  7. Rachoń D, Pokrywka L, Suchecka-RachońK. Prevalence and risk factors of anabolic-androgenic steroids (AAS) abuse among adolescents and young adults in Poland. Soz Praventiv Med. 2006;51(6):392-398.
  8. Hazavei SMM, Abdolmaleki MH. Study of Anabolic Androgenic Steroids use   in bodybuilding athletes in Hamadan. Scientific Journal of Hamadan University of Medical Sciences. 1999;6(12):31-38. [Persian]
  9. Tahtamouni LH, Mustafa NH, Alfaouri AA, Hassan IM, Abdalla MY, Yasin SR. Prevalence and risk factors for anabolic-androgenic steroid abuse among Jordanian collegiate students and athletes. Eur J Public Health. 2008;18(6):661-665.
  10. Angoorani H, Narenjiha H, Tayyebi B, Ghassabian A, Ahmadi G, Assari S. Amphetamine use and its associated factors in body builders: a study from Tehran, Iran. Arch Med Sci. 2012;8(2):362-367.
  11. Khooshabi K, Ameneh-Forouzan S, Ghassabian A, Assari S. Is there a gender difference in associates of adolescents' lifetime illicit drug use in Tehran, Iran? Arch Med Sci. 2010;6(3):399-406.
  12. Kanayama G, Hudson JI, Pope HG Jr. Long term psychiatric and medical consequences of anabolic-androgenic steroid abuse: a looming public health concern? Drug Alcohol Depend. 2008; 98(1-2):1-12.
  13. Delbeke FT, Desmet N, DebackereM. The abuse of doping agents in competing body builders in Flanders (19881993). Int J Sports Med. 1995;16:66-70.
  14. Johnson MD, Jay MS, Shoup B, Rickert VI. Anabolic steroid use by male adolescents. Pediatrics. 1989;83:921-924.
  15. Hakansson A, Mickelsson K, Wallin C, Berglund M. Anabolic androgenic steroids in the general population: user characteristics and associations with substance use. Eur Addict Res. 2012;18(2):83-90.
  16. Parkinson AB, Evans NA. Anabolic androgenic steroids: a survey of 500 users. Med Sci Sports Exerc. 2006;38(4):644-651.
  17. Kindlundh AM, Hagekull B, Isacson DG. Adolescent use of anabolic-androgenic steroids and relations to self-reports of social, personality and health aspects. Eur J Public Health. 2001;11:322-328.
  18. Habeeb MB, Kasim WJ, Khamees LA, Hawi MM, Khashoom QN. Athletes' perceptions toward substance use in Baghdad city. Am J Mens Health. 2012;6(6):462-471.
  19. Baker JS, Graham M, Davies B. Gym users and abuse of prescription drugs. J R Soc Med. 2006;99(7):331-332.
  20. Goldberg, L, Bosworth E, Bents R, Trevisan L. Anabolic steroid education and adolescents: do scare tactics work? Pediatrics. 1991;87:283-286.


JRHS Office:

School of Public Health, Hamadan University of Medical Sciences, Shaheed Fahmideh Ave. Hamadan, Islamic Republic of Iran

Postal code: 6517838695, PO box: 65175-4171

Tel: +98 81 38380292, Fax: +98 81 38380509

E-mail: jrhs@umsha.ac.ir